Lixte Biotechnology (LIXT) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free LIXT Stock Alerts $2.46 +0.08 (+3.36%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lixte Biotechnology Short Interest DataCurrent Short Volume23,600 sharesPrevious Short Volume82,700 sharesChange Vs. Previous Month-71.46%Dollar Volume Sold Short$68,204.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares2,250,000 sharesFloat Size1,800,000 sharesShort Percent of Float1.31%Today's Trading Volume7,517 sharesAverage Trading Volume15,344 sharesToday's Volume Vs. Average49% Short Selling Lixte Biotechnology ? Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLIXT Short Interest Over TimeLIXT Days to Cover Over TimeLIXT Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Lixte Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202423,600 shares $68,204.00 -71.5%1.3%0 $2.89 4/15/202482,700 shares $272,910.00 +395.2%4.6%0.2 $3.30 3/31/202416,700 shares $56,446.00 -14.8%1.0%0 $3.38 3/15/202419,600 shares $45,276.00 -62.3%1.1%0.5 $2.31 2/29/202452,000 shares $135,200.00 +258.6%3.0%1.4 $2.60 2/15/202414,500 shares $39,440.00 +42.2%0.8%0.3 $2.72 Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/31/202410,200 shares $21,063.00 +117.0%0.6%0.4 $2.07 1/15/20244,700 shares $9,118.00 -63.0%0.3%0.1 $1.94 12/31/202312,700 shares $29,845.00 -32.5%0.7%0.3 $2.35 12/15/202318,800 shares $39,668.00 -26.0%1.1%0.4 $2.11 11/30/202325,400 shares $59,182.00 -60.1%1.5%0.5 $2.33 11/15/202363,700 shares $184,730.00 +295.7%3.7%1.2 $2.90 10/31/202316,100 shares $38,720.50 -1.8%0.9%0.4 $2.41 10/15/202316,400 shares $39,360.00 -44.6%1.0%0.3 $2.40 9/30/202329,600 shares $72,520.00 +261.0%2.1%0.2 $2.45 9/15/20238,200 shares $17,384.00 +13.9%0.6%0.1 $2.12 8/31/20237,200 shares $18,036.00 -44.2%0.3%0.1 $2.51 8/15/202312,900 shares $32,250.00 -84.3%0.6%0.1 $2.50 7/31/202382,200 shares $289,344.00 +774.5%4.7%0.6 $3.52 7/15/20239,400 shares $51,042.00 +8.1%1.0%0.1 $5.43 6/30/20238,700 shares $50,721.00 -28.7%0.5%0.4 $5.83 6/15/202312,200 shares $57,950.00 +306.7%1.5%0.7 $4.75 5/31/20233,000 shares $20,784.00 -86.2%0.4%0.3 $6.93 5/15/202321,800 shares $14,483.92 +162.7%0.3%0.2 $0.66 4/30/20238,300 shares $4,656.30 -80.0%0.1%0 $0.56 4/15/202341,500 shares $26,153.30 -45.8%0.5%0 $0.63 3/31/202376,500 shares $63,288.45 -39.1%1.0%0.1 $0.83 3/15/2023125,700 shares $85,853.10 +31.5%1.7%0.1 $0.68 2/28/202395,600 shares $86,757.00 -38.7%1.3%0.1 $0.91 2/15/2023156,000 shares $180,960.00 +459.1%2.1%0.1 $1.16 1/31/202327,900 shares $22,041.00 -62.6%0.4%0 $0.79 1/15/202374,500 shares $42,465.00 +89.1%1.0%2 $0.57 12/30/202239,400 shares $20,054.60 -7.9%0.5%1.2 $0.51 12/15/202242,800 shares $23,171.92 -15.9%0.6%1.7 $0.54 11/30/202250,900 shares $38,938.50 +53.3%0.7%1.8 $0.77 11/15/202233,200 shares $18,283.24 +26.7%0.5%1.1 $0.55 10/31/202226,200 shares $13,105.24 +5.2%0.4%0.5 $0.50 10/15/202224,900 shares $12,980.37 -58.5%0.4%0.2 $0.52 9/30/202260,000 shares $33,612.00 +64.4%0.9%0.5 $0.56 9/15/202236,500 shares $25,761.70 -43.4%0.5%0.3 $0.71Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now LIXT Short Interest - Frequently Asked Questions What is Lixte Biotechnology's current short interest? Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 23,600 shares of LIXT short. 1.31% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest. What is a good short interest percentage for Lixte Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.31% of Lixte Biotechnology's floating shares are currently sold short. Is Lixte Biotechnology's short interest increasing or decreasing? Lixte Biotechnology saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 23,600 shares, a decrease of 71.5% from the previous total of 82,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lixte Biotechnology's float size? Lixte Biotechnology currently has issued a total of 2,250,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 1,800,000 shares. How does Lixte Biotechnology's short interest compare to its competitors? 1.31% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lixte Biotechnology: Kineta, Inc. (1.96%), Enveric Biosciences, Inc. (1.07%), Adial Pharmaceuticals, Inc. (4.42%), First Wave BioPharma, Inc. (2.39%), Lipella Pharmaceuticals Inc. (1.05%), Xenetic Biosciences Inc (0.50%), Hoth Therapeutics, Inc. (2.73%), Processa Pharmaceuticals, Inc. (24.82%), Genprex, Inc. (2.46%), Sonnet BioTherapeutics Holdings, Inc. (14.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lixte Biotechnology stock? Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. LIXT shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lixte Biotechnology? A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further. How often is Lixte Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: KA Short Interest Data ENVB Short Interest Data ADIL Short Interest Data FWBI Short Interest Data LIPO Short Interest Data XBIO Short Interest Data HOTH Short Interest Data PCSA Short Interest Data GNPX Short Interest Data SONN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LIXT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media41 banks launch ‘crypto dollar’Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford Club